Alexandria Real Estate Equities Inc (ARE)

NYSE
Currency in USD
75.74
-2.10(-2.70%)
Closed·
After Hours
75.12-0.62(-0.82%)
·
ARE Scorecard
Full Analysis
Has raised its dividend for 14 consecutive years
Earnings results expected in 6 days
Fair Value
Day's Range
74.4676.79
52 wk Range
71.57130.14
Key Statistics
Edit
Prev. Close
77.84
Open
76.47
Day's Range
74.46-76.79
52 wk Range
71.57-130.14
Volume
1.53M
Average Vol. (3m)
1.51M
1-Year Change
-32.72%
Book Value / Share
102.36
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ARE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
114.15
Upside
+50.72%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year
Show more

Alexandria Real Estate Equities Inc Company Profile

Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. As the pioneer of the life science real estate niche with our founding in 1994, Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative mega campuses in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. As of September 30, 2024, Alexandria has a total market capitalization of $33.1 billion and an asset base in North America that includes 41.8 million RSF of operating properties, 5.3 million RSF of Class A/A+ properties undergoing construction, and one committed near-term project expected to commence construction in the next two years. Alexandria has a longstanding and proven track record of developing Class A/A+ properties clustered in mega campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.

Alexandria Real Estate Equities Inc SWOT Analysis


Market Outlook
Analyst price targets average $130, reflecting optimism for ARE's long-term prospects in the evolving life sciences real estate landscape
Strategic Development
Delve into Alexandria's 7.0 million square feet development pipeline, with over half pre-leased, showcasing continued demand for high-quality assets
Financial Resilience
Explore ARE's solid financial performance, with Core FFO meeting expectations and a robust balance sheet, despite near-term industry headwinds
Life Sciences Leade
Alexandria Real Estate Equities, a top REIT in life sciences properties, navigates market challenges while positioning for long-term growth in prime locations
Read full SWOT analysis

Alexandria Real Estate Equities Inc Earnings Call Summary for Q4/2024

  • Annual revenue fell 9% to $4.2B; operating loss of $60M vs. $241M profit in 2023; backlog grew to $6.7B
  • New contract awards increased to $4.7B; company expanding U.S. presence, targeting $150-200M in nuclear work for 2025
  • Anticipates revenue growth in 2025; focus on margin improvement, project execution, and U.S. market expansion
  • CEO emphasizes role as builder, not manufacturer; prioritizes collaborative design-build contracts and project execution
  • Challenges include fluctuating construction demand, potential tariff impacts, and increased North American competition
Last Updated: 03/06/2025, 09:56 AM
Read Full Transcript

Compare ARE to Peers and Sector

Metrics to compare
ARE
Peers
Sector
Relationship
P/E Ratio
43.5x33.5x8.2x
PEG Ratio
0.180.720.01
Price / Book
0.8x2.0x0.9x
Price / LTM Sales
4.3x8.7x3.5x
Upside (Analyst Target)
46.8%12.9%20.8%
Fair Value Upside
Unlock−3.9%3.5%Unlock

Analyst Ratings

4 Buy
9 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 114.15
(+50.72% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.80%
Dividend Yield
6.78%
Industry Median 5.09%
Annualized Payout
5.28
Paid quarterly
5-Years Growth
+5.35%
Growth Streak

Earnings

Latest Release
Jan 27, 2025
EPS / Forecast
-0.38 / 0.92
Revenue / Forecast
788.95M / 778.72M
EPS Revisions
Last 90 days

People Also Watch

83.55
TROW
-2.97%
32.15
VICI
-1.20%
98.59
PLD
-3.44%
166.17
AVGO
-2.82%

FAQ

What Is the Alexandria RE (ARE) Stock Price Today?

The Alexandria RE stock price today is 75.74

What Stock Exchange Does Alexandria RE Trade On?

Alexandria RE is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for Alexandria RE?

The stock symbol for Alexandria RE is "ARE."

Does Alexandria RE Pay Dividends? What’s The Current Dividend Yield?

The Alexandria RE dividend yield is 6.97%.

What Is the Alexandria RE Market Cap?

As of today, Alexandria RE market cap is 13.07B.

What is Alexandria RE Earnings Per Share?

The Alexandria RE EPS is 1.80.

What Is the Next Alexandria RE Earnings Date?

Alexandria RE will release its next earnings report on Apr 28, 2025.

From a Technical Analysis Perspective, Is ARE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.